BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25202105)

  • 1. 8-Isoprostane in exhaled breath condensate of patients with non-small cell lung cancer: the effect of chemotherapy.
    Stathopoulos D; Loukides S; Syrigos K
    Anticancer Res; 2014 Sep; 34(9):5143-5. PubMed ID: 25202105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer.
    Dalaveris E; Kerenidi T; Katsabeki-Katsafli A; Kiropoulos T; Tanou K; Gourgoulianis KI; Kostikas K
    Lung Cancer; 2009 May; 64(2):219-25. PubMed ID: 18845357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated levels of oxidative stress markers in exhaled breath condensate.
    Chan HP; Tran V; Lewis C; Thomas PS
    J Thorac Oncol; 2009 Feb; 4(2):172-8. PubMed ID: 19179892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of oxidative stress using exhaled breath 8-isoprostane levels on chronic kidney disease.
    Tiryaki BS; Tasliyurt T; Yelken BM; Sahin S; Kutluturk F; Koseoglu HI; Ozturk B; Yilmaz A; Sahin S
    Niger J Clin Pract; 2014; 17(3):356-60. PubMed ID: 24714017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 8-isoprostane in exhaled breath condensate after experimental exposure to wood smoke in humans.
    Murgia N; Barregard L; Sallsten G; Almstrand AC; Montuschi P; Ciabattoni G; Olin AC
    J Biol Regul Homeost Agents; 2016; 30(1):263-70. PubMed ID: 27049101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3p microsatellite alterations in exhaled breath condensate from patients with non-small cell lung cancer.
    Carpagnano GE; Foschino-Barbaro MP; Mulé G; Resta O; Tommasi S; Mangia A; Carpagnano F; Stea G; Susca A; Di Gioia G; De Lena M; Paradiso A
    Am J Respir Crit Care Med; 2005 Sep; 172(6):738-44. PubMed ID: 15947287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress in cystic fibrosis patients with Burkholderia cenocepacia airway colonization: relation of 8-isoprostane concentration in exhaled breath condensate to lung function decline.
    Fila L; Grandcourtová A; Chládek J; Musil J
    Folia Microbiol (Praha); 2014 May; 59(3):217-22. PubMed ID: 24132725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased alveolar nitric oxide concentration and high levels of leukotriene B(4) and 8-isoprostane in exhaled breath condensate in patients with asbestosis.
    Lehtonen H; Oksa P; Lehtimäki L; Sepponen A; Nieminen R; Kankaanranta H; Saarelainen S; Järvenpää R; Uitti J; Moilanen E
    Thorax; 2007 Jul; 62(7):602-7. PubMed ID: 17251310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients.
    Montuschi P; Corradi M; Ciabattoni G; Nightingale J; Kharitonov SA; Barnes PJ
    Am J Respir Crit Care Med; 1999 Jul; 160(1):216-20. PubMed ID: 10390403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exhaled 8-isoprostane in childhood asthma.
    Shahid SK; Kharitonov SA; Wilson NM; Bush A; Barnes PJ
    Respir Res; 2005 Jul; 6(1):79. PubMed ID: 16042771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exhaled markers of oxidative stress in idiopathic pulmonary fibrosis.
    Psathakis K; Mermigkis D; Papatheodorou G; Loukides S; Panagou P; Polychronopoulos V; Siafakas NM; Bouros D
    Eur J Clin Invest; 2006 May; 36(5):362-7. PubMed ID: 16634841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excision-repair-cross-complement-1 protein as a prognostic factor in patients with advanced non-small cell lung cancer treated with platinum-based first-line chemotherapy.
    Vassalou H; Stathopoulos E; Fiolitaki G; Koutsopoulos A; Voutsina A; Georgoulias V; Mavroudis D
    Lung Cancer; 2013 Nov; 82(2):324-9. PubMed ID: 23993732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Could exhaled ferritin and SOD be used as markers for lung cancer and prognosis prediction purposes?
    Carpagnano GE; Lacedonia D; Palladino GP; Koutelou A; Martinelli D; Orlando S; Foschino-Barbaro MP
    Eur J Clin Invest; 2012 May; 42(5):478-86. PubMed ID: 21955247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 8-Isoprostane in nasally exhaled breath condensate in different pediatric lung diseases.
    Latzin P; Beck-Ripp J; Hartl D; Bartenstein A; Noss J; Griese M
    Eur J Med Res; 2007 Jan; 12(1):21-5. PubMed ID: 17363354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentration of exhaled breath condensate biomarkers after fractionated collection based on exhaled CO2 signal.
    Goldoni M; Corradi M; Mozzoni P; Folesani G; Alinovi R; Pinelli S; Andreoli R; Pigini D; Tillo R; Filetti A; Garavelli C; Mutti A
    J Breath Res; 2013 Mar; 7(1):017101. PubMed ID: 23445573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of exhaled microsatellite alterations at 3p in NSCLC patients.
    Carpagnano GE; Spanevello A; Carpagnano F; Palladino GP; Prato R; Martinelli D; Digioia G; Foschino-Barbaro MP
    Lung Cancer; 2009 Jun; 64(3):334-40. PubMed ID: 18995925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 8-isoprostane levels in serum and bronchoalveolar lavage in idiopathic pulmonary fibrosis and sarcoidosis.
    Malli F; Bardaka F; Tsilioni I; Karetsi E; Gourgoulianis KI; Daniil Z
    Food Chem Toxicol; 2013 Nov; 61():160-3. PubMed ID: 23702326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of oxidative status with exhaled breath 8-isoprostane levels in patients with hyperthyroidism.
    Bastug E; Tasliyurt T; Kutluturk F; Sahin S; Yilmaz A; Sivgin H; Yelken BM; Ozturk B; Yilmaz A; Sahin S
    Endocr Metab Immune Disord Drug Targets; 2013 Dec; 13(4):306-10. PubMed ID: 24107071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and feasibility of exhaled breath condensate collection in ventilated infants and children.
    Muller WG; Morini F; Eaton S; Peters M; Jaffe A
    Eur Respir J; 2006 Sep; 28(3):479-85. PubMed ID: 16641124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapy.
    Berghmans T; Lafitte JJ; Thiriaux J; VanHoutte P; Lecomte J; Efremidis A; Koumakis G; Giner V; Richez M; Corhay JL; Wackenier P; Lothaire P; Mommen P; Ninane V; Sculier JP;
    Lung Cancer; 2004 Sep; 45(3):339-48. PubMed ID: 15301874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.